Strictly private & confidential
The clinical-intelligence layer a fertility network can own — not rent.
An exclusive enterprise licence to the Fertificially™ platform — your network holds it, competitors don’t, and a pre-agreed option converts control into ownership. Enter your details and accept the confidentiality agreement to review.
  • $3.75M exclusive licence · $100 per-patient royalty · option to own
  • Live product walkthrough and an interactive deal model inside
  • Five-document package: offer, structure, platform, value, regulatory
  • Every page confidential, view-only and watermarked to you
ClariaDX LLC · Miami, Florida contact@clariadx.com · www.fertificially.com ↗
Request access · Step 1 of 2
Your details & the confidentiality agreement
Enter your information below. The agreement fills in with your details as you type — no paperwork, no printing. Accepting is a binding electronic signature.
Non-Disclosure & Confidentiality Agreement
Auto-filled · Florida law

This Non-Disclosure & Confidentiality Agreement (this “Agreement”) is entered into and effective as of the date of acceptance, by and between ClariaDX LLC, a Florida limited liability company with its principal office in Miami, Florida (the “Company”), and [your name] (the “Recipient”), reachable at [your email].

1 · Confidential Information

The Recipient will receive materials concerning the Fertificially™ platform and a potential strategic transaction, including the offering letter, transaction structure and economics, platform documentation, strategic value analysis, regulatory materials, product demonstrations and related information (together, the “Confidential Information”), disclosed by ClariaDX LLC (the “Company”) solely for the Recipient’s evaluation of a potential acquisition, licence, partnership or similar strategic transaction (the “Permitted Purpose”).

2 · Non-use & permitted recipients

The Recipient will use the Confidential Information only for the Permitted Purpose, will not disclose it to any person except its directors, officers, employees and professional advisers who need it for the Permitted Purpose and are bound by confidentiality obligations no less protective, and will remain responsible for their compliance. The Recipient will not copy, forward, publish, screenshot for distribution, reverse engineer or otherwise exploit the Confidential Information.

3 · Independent evaluation

Nothing here restricts the Recipient from evaluating or investing in other companies, provided the Confidential Information is not used or disclosed.

4 · No offer; no obligation

The Confidential Information is provided for evaluation only. Nothing in this Agreement or the Confidential Information constitutes an offer capable of acceptance, and neither party is under any obligation to negotiate or conclude any transaction; any transaction would be subject to due diligence and definitive written agreements executed by both parties.

5 · Term

The Recipient's confidentiality obligations continue for three (3) years from the date of acceptance; obligations relating to trade secrets continue for so long as the information remains a trade secret.

6 · Governing law & disputes

This Agreement is governed by the laws of the State of Florida, without regard to its conflict-of-laws rules. Any dispute will be resolved by binding arbitration in Miami-Dade County, Florida, under the rules of the American Arbitration Association.

7 · Recipient representations & acknowledgments

The Recipient represents and acknowledges that: (a) it received access to these materials through a direct, personal communication from the Company or its representatives; (b) it is evaluating the Confidential Information on behalf of the organization named above; (c) the Confidential Information includes commercially sensitive terms whose disclosure would cause the Company competitive harm; and (d) no representation or warranty is made as to the completeness or accuracy of the Confidential Information, on which the Recipient will rely only as, and to the extent, set out in definitive agreements.

8 · Electronic acceptance

By typing your name and clicking “Agree & enter,” you confirm you are authorised to accept on behalf of the Recipient and that your typed name and click constitute a valid, binding electronic signature under the U.S. Electronic Signatures in Global and National Commerce Act and the Florida Uniform Electronic Transaction Act.

⚠ Important notices — please read before entering
No offer; no obligation. This material is for evaluation only and does not constitute an offer capable of acceptance; any transaction is subject to diligence and definitive agreements.
Early-stage asset. The platform is early-stage and pre-clearance; illustrations of utilisation, revenue and value are assumptions, not assurances. Conduct your own due diligence.
Forward-looking. Projections, timelines, regulatory pathways and the financial model are forward-looking and subject to significant uncertainty; actual results may differ materially.
Investigational device. Fertificially is not cleared or approved by the U.S. FDA or any regulator. No clinical performance claim is made; it is not an embryo selector and does not predict implantation or live birth.
No reliance. Information is provided “as is,” without representation or warranty. Conduct your own due diligence and consult your own legal, tax and investment advisors.
Confidential. Provided under NDA for your evaluation only — do not copy, forward or distribute. Full disclosures, including related-party and intellectual-property matters, are inside the room.
Your signature appears here
This acceptance will be recorded as: [complete the form above] · with timestamp and IP, for the Company's records.
Verify your email · Step 2 of 2
Enter your 6-digit code
To confirm it's really you, we emailed a 6-digit code to your email. Enter it below to open the room. The code expires in 10 minutes.
Didn't get it? Check spam, or resend the code.